Skip to main content


What's new

Earlier this month, the FDA approved the once-daily oral drug Tradjenta (Boehringer Ingelheim and Eli Lilly’s... Continue Reading »

The FDA’s decision on Bydureon was a shocker. We break down this decision and discuss why we view it as such a disappointment. Continue Reading »

Kelly laments the FDA's latest disappointing decision and extends a personal invitation to celebrate World Diabetes Day with the diaTribe team. Continue Reading »